All Stories

  1. Indications and timing of renal replacement therapy
  2. Continuous Renal Replacement Therapies for Acute Kidney Injury
  3. Neutrophil Gelatinase-Associated Lipocalin as a Promising Biomarker in Acute Kidney Injury
  4. MO423PROENKEPHALIN AS A BIOMARKER OF KIDNEY FILTRATION IN ACUTE KIDNEY INJURY
  5. Management options: Continuous renal replacement therapy
  6. Indications for Continuous Renal Replacement Therapy
  7. Starting and Stopping Renal Replacement Therapy in the Critically Ill
  8. Conservative Management of Acute Kidney Injury
  9. Urinary Biochemistry in the Diagnosis of Acute Kidney Injury
  10. Inclusion and definition of acute renal dysfunction in critically ill patients in randomized controlled trials: a systematic review
  11. Conservative Management of Acute Kidney Injury
  12. 051 EFFICACY OF KETOSTERIL VERSUS LOW PROTEIN DIE IN PREVENTING PROGRESSION OF AKI TO CKD: METHODOLOGY
  13. Acute Kidney Injury Risk Assessment: Differences and Similarities Between Resource-Limited and Resource-Rich Countries
  14. A risk prediction score for acute kidney injury in the intensive care unit
  15. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup
  16. A clinical score to predict mortality in septic acute kidney injury patients requiring continuous renal replacement therapy: the HELENICC score
  17. Guiding Physician Decisions for Initiating Dialysis for AKI: Is Progress on the Horizon?
  18. Rationale and Design of the Genetic Contribution to Drug Induced Renal Injury (DIRECT) Study
  19. Continuous Dialysis Therapies: Core Curriculum 2016
  20. Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study
  21. Preventing organ dysfunction — is preconditioning still an option?
  22. Preventing Acute Kidney Injury
  23. Renal Outcomes in Critically Ill Patients Receiving Propofol or Midazolam
  24. Sustained low-efficiency extended dialysis (SLED) with single-pass batch system in critically-ill patients with acute kidney injury (AKI)
  25. Phenotype standardization for drug-induced kidney disease
  26. SP230RENAL OUTCOMES IN CRITICALLY ILL PATIENTS RECEIVING PROPOFOL OR MIDAZOLAM A PROPENSITY SCORING ANALYSIS
  27. Urine Output Assessment as a Clinical Quality Measure
  28. Targeting Recovery from Acute Kidney Injury: Incidence and Prevalence of Recovery
  29. Clinical Determinants of Renal Recovery
  30. Recurrent Clotting of Dialysis Filter Associated With Hypertriglyceridemia Induced by Propofol
  31. Anticoagulation, delivered dose and outcomes in CRRT: The program to improve care in acute renal disease (PICARD)
  32. Clinical Approach to the Diagnosis of Acute Kidney Injury
  33. Fractional excretion of potassium in the course of acute kidney injury in critically ill patients: potential monitoring tool?
  34. Association between renal replacement therapy in critically ill patients with severe acute kidney injury and mortality
  35. Measuring renal function in critically ill patients
  36. Physicochemical analysis of blood and urine in the course of acute kidney injury in critically ill patients: a prospective, observational study
  37. Timing of Dialysis Initiation in Acute Kidney Injury and Acute‐On‐Chronic Renal Failure
  38. Role of MELD Score and Serum Creatinine as Prognostic Tools for the Development of Acute Kidney Injury after Liver Transplantation
  39. Differential Diagnosis of AKI in Clinical Practice by Functional and Damage Biomarkers: Workgroup Statements from the Tenth Acute Dialysis Quality Initiative Consensus Conference
  40. Timing of renal replacement therapy initiation by AKIN classification system
  41. Monitorização de eletrólitos urinários em pacientes críticos: estudo preliminar observacional
  42. Long-Term Follow-Up of Patients after Acute Kidney Injury: Patterns of Renal Functional Recovery
  43. Tailored Therapy: Matching the Method to the Patient
  44. Management options: continuous renal replacement therapy
  45. Contrast-induced nephropathy: attributable incidence and potential harm
  46. Toward the optimal dose metric in continuous renal replacement therapy
  47. Effluent volume and dialysis dose in CRRT: time for reappraisal
  48. Oliguria is an early predictor of higher mortality in critically ill patients
  49. A dangerous entanglement
  50. Urine Microscopy in Acute Kidney Injury: Time for a Change
  51. Introduction
  52. When Should Renal Replacement Therapy be Initiated for Acute Kidney Injury?
  53. Blood urea nitrogen beyond estimation of renal function*
  54. Dosing of Renal Replacement Therapy in Acute Kidney Injury: Lessons Learned From Clinical Trials
  55. Prerenal Azotemia in Congestive Heart Failure
  56. Dialytic Management for Acute Renal Failure
  57. Prevention and Nondialytic Management of Acute Kidney Injury
  58. Early vs late start of dialysis: it's all about timing
  59. Fluid accumulation, recognition and staging of acute kidney injury in critically-ill patients
  60. Prerenal failure: from old concepts to new paradigms
  61. Discontinuation of continuous renal replacement therapy: A post hoc analysis of a prospective multicenter observational study*
  62. Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury
  63. Renal recovery following acute kidney injury
  64. Impact of Mild Acute Kidney Injury (AKI) on Outcome after Open Repair of Aortic Aneurysms
  65. Continuous renal replacement therapy: A worldwide practice survey
  66. External validation of severity scoring systems for acute renal failure using a multinational database
  67. Diuretics and mortality in acute renal failure*
  68. Insuficiência renal aguda relacionada à correção de aneurisma da aorta: análise retrospectiva dos fatores de risco e estudo prospectivo para sua prevenção